aphidicolin and Carcinoma--Intraductal--Noninfiltrating

aphidicolin has been researched along with Carcinoma--Intraductal--Noninfiltrating* in 1 studies

Other Studies

1 other study(ies) available for aphidicolin and Carcinoma--Intraductal--Noninfiltrating

Article	Year
The expression of aphidicolin-induced fragile sites in familial breast cancer patients. Cancer genetics and cytogenetics, 1993, Volume: 67, Issue:2 The expression frequency of aphidicolin-induced fragile sites was examined in familial breast cancer patients to determine whether this parameter could be used as a marker of genetic susceptibility in at-risk individuals. No difference was found in expression frequency between the breast cancer patients and a group of normal individuals (p = 0.61). This indicates that the expression frequency of aphidicolin-induced fragile sites is not a suitable marker for assessing genetic susceptibility in familial breast cancer. Topics: Adenocarcinoma; Adult; Aged; Aphidicolin; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cells, Cultured; Chromosome Fragile Sites; Chromosome Fragility; Female; Humans; Middle Aged	1993

Article

Year

The expression of aphidicolin-induced fragile sites in familial breast cancer patients.

Cancer genetics and cytogenetics, 1993, Volume: 67, Issue:2

The expression frequency of aphidicolin-induced fragile sites was examined in familial breast cancer patients to determine whether this parameter could be used as a marker of genetic susceptibility in at-risk individuals. No difference was found in expression frequency between the breast cancer patients and a group of normal individuals (p = 0.61). This indicates that the expression frequency of aphidicolin-induced fragile sites is not a suitable marker for assessing genetic susceptibility in familial breast cancer.

Topics: Adenocarcinoma; Adult; Aged; Aphidicolin; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cells, Cultured; Chromosome Fragile Sites; Chromosome Fragility; Female; Humans; Middle Aged

1993